Sekisui Chemical Co., Ltd. - Investment in PeptiStar Inc.
Leading Japanese law firm Nishimura & Asahi has advised Sekisui Chemical Co., Ltd. (“Sekisui”) on its additional investment in joint-venture company PeptiStar Inc. (“PeptiStar”). PeptiStar expects to raise additional funds from 17 investors, including Sekisui, PeptiDream Inc. (“PeptiDream”), Shionogi & Co., Ltd. (“Shionogi”) and Innovation Network Corporation of Japan.
In 2017, Sekisui, PeptiDream and Shionogi formed PeptiStar to set up a contract manufacturing organization for research, development, manufacturing, and commercialization of peptide therapeutics.
Sekisui [TYO: 4204], established in 1947 and headquartered in Osaka, Japan, is a developer of plastic-mold processes and new materials and technologies, and offers a vast array of products and services in fields ranging from housing and urban infrastructure to the electronics, automotive, and other advanced-technology fields around the world.
The Nishimura & Asahi team advising Sekisui was led by partners Takuya Matsuo and Tatsuya Nakayama.
People
Tatsuya Nakayama is a partner in our M&A and corporate practice and was previously seconded to a top-tier U.S. international law firm. He has represented Japanese and non-Japanese buyers and sellers in numerous domestic and cross-border M&A and other commercial transactions, including financial institutions M&A, strategic alliances, private equity, equity finance, startups and venture capital investments. He also has considerable expertise in strategy planning at all stages from early stage to PMI and advises on a broad range of legal issues in the field of general corporate matters, including corporate governance, and banking and insurance. Leveraging such significant expertise and experience, he provides attentive expert advice in an effective, practical and timely manner. He also has experience serving as an outside officer for private companies and as a lecturer at a prestigious university and law school in Japan.